Conference on protein toxins and their effects on bacteria
Official title: 2024 Lakeside Conference on Protein Toxins and Effectors
Funded at University of Illinois at Urbana-Champaign · NIH-11003432 · Data updated 2026-11-12
This conference is all about bringing together scientists to learn how harmful bacteria use special proteins to make us sick, and they'll be using cool tools to dig deeper into how these proteins work and affect our cells.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Urbana-Champaign NIH-funded |
| Lab location | 1 site (Champaign, United States) |
| Project start | August 1, 2024 |
| Project end | July 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $7,000 |
| NIH project number | 1R13AI186530-01 |
| Project ID | NIH-11003432 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients suffering from diseases linked to bacterial toxins, such as botulism or cholera, may benefit from the advancements discussed at this conference.
✕Less likely to help
Patients with non-bacterial infections or conditions unrelated to protein toxins may not receive any benefit from this research.
What this research studies
This conference focuses on the role of protein toxins and effectors produced by pathogenic bacteria in causing diseases. It aims to bring together researchers to share findings and collaborate on understanding how these toxins disrupt essential functions in target cells. The event will utilize advanced techniques such as CRISPR and cryo-electron microscopy to explore the structure and function of these toxins. By fostering interdisciplinary collaboration, the conference seeks to enhance the dissemination of knowledge in this rapidly evolving field.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and potential treatments for diseases caused by bacterial toxins.
How similar studies have gone: Previous conferences and research initiatives focusing on bacterial toxins have successfully advanced the field, indicating a strong potential for impactful outcomes.
Where this research is happening
-
University of Illinois at Urbana-Champaign
Champaign, United States Active
Researchers
- Principal investigator: Blanke, Steven R. — University of Illinois at Urbana-Champaign
- Study coordinator: Blanke, Steven R.
Related research
Other NIH-funded projects on the same topics.
-
Counterfactual explanations for AI-assisted cancer diagnosis and subtyping
A cancer-diagnosis AI tool will be made easier to understand by showing counterfactual explanations that reveal how changing histopathology images could change the model’s prediction.
-
A 3D ultrasound scanner to see early chemotherapy response in breast cancer
A new 3D ultrasound imaging method will be tested to see if it can quickly show whether breast cancer is responding to chemotherapy.
-
Upgrading automated antimicrobial testing equipment to support animal health surveillance
A university veterinary lab is upgrading its automatic system to read and incubate samples so it can continue tracking antibiotic resistance in animals and pet foods.
-
Hybridization capture sequencing to quickly identify canine urinary pathogens and resistance genes
A new sequencing approach directly from dog urine aims to rapidly identify bacteria causing urinary infections and their drug-resistance profiles to guide treatment.
-
Wearable biofeedback device to help swallowing after neurologic injury
This project helps people with swallowing problems from neurologic conditions use a small wearable sensor that shows neck muscle activity to guide exercises and improve swallowing.
-
Phthalate exposure and aging of the female reproductive system
This project looks at how certain plastics chemicals may speed up aging of the female reproductive system and affect fertility and health.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.